Gyre Therapeutics (GYRE) announced Han Ying has stepped down as CEO and will transition into the role of senior VP, science and will oversee research and discovery activities to support Gyre’s fibrosis focused pipeline. Ping Zhang, executive chairman, has been appointed interim CEO, and will lead the company’s day-to-day operations and strategic global expansion.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GYRE: